LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 66.33 | 21.74 | 2640 | 6235 | 0.4234 | 0.8002 | MN20160310_N01 | M14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 68.30 | 21.74 | 2558 | 6244 | 0.4096 | 0.7929 | MN20160310_N01 | H06 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 68.30 | 21.74 | 2666 | 6244 | 0.4269 | 0.8020 | MN20160310_N01 | H06 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 68.30 | 21.74 | 185 | 6244 | 0.0296 | 0.2998 | MN20160310_N01 | M14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 68.30 | 21.74 | 2613 | 6244 | 0.4184 | 0.7976 | MN20160310_N01 | M14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 70.27 | 21.74 | 2798 | 6201 | 0.4512 | 0.8140 | MN20160310_N01 | H06 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 70.27 | 21.74 | 2817 | 6201 | 0.4542 | 0.8156 | MN20160310_N01 | H06 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 70.27 | 21.74 | 201 | 6201 | 0.0324 | 0.3135 | MN20160310_N01 | M14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 70.27 | 21.74 | 2805 | 6201 | 0.4523 | 0.8146 | MN20160310_N01 | M14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 72.24 | 21.74 | 2897 | 6162 | 0.4701 | 0.8230 | MN20160310_N01 | H06 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 72.24 | 21.74 | 2913 | 6162 | 0.4727 | 0.8243 | MN20160310_N01 | H06 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 72.24 | 21.74 | 243 | 6162 | 0.0394 | 0.3449 | MN20160310_N01 | M14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 72.24 | 21.74 | 2930 | 6162 | 0.4755 | 0.8256 | MN20160310_N01 | M14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 74.21 | 21.74 | 2970 | 6235 | 0.4763 | 0.8263 | MN20160310_N01 | H06 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 74.21 | 21.74 | 2988 | 6235 | 0.4792 | 0.8277 | MN20160310_N01 | H06 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 74.21 | 21.74 | 248 | 6235 | 0.0398 | 0.3474 | MN20160310_N01 | M14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 74.21 | 21.74 | 2894 | 6235 | 0.4641 | 0.8205 | MN20160310_N01 | M14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 76.18 | 21.74 | 3112 | 6114 | 0.5090 | 0.8407 | MN20160310_N01 | H06 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 76.18 | 21.74 | 3132 | 6114 | 0.5122 | 0.8421 | MN20160310_N01 | H06 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 76.18 | 21.74 | 284 | 6114 | 0.0464 | 0.3715 | MN20160310_N01 | M14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 76.18 | 21.74 | 3075 | 6114 | 0.5029 | 0.8380 | MN20160310_N01 | M14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 78.15 | 21.74 | 3233 | 6167 | 0.5242 | 0.8476 | MN20160310_N01 | H06 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 78.15 | 21.74 | 3248 | 6167 | 0.5266 | 0.8486 | MN20160310_N01 | H06 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 78.15 | 21.74 | 322 | 6167 | 0.0522 | 0.3921 | MN20160310_N01 | M14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 78.15 | 21.74 | 3167 | 6167 | 0.5135 | 0.8429 | MN20160310_N01 | M14 |